De Smet Arne, Vanhove Wim, Benis Szabolcs, Verstraete Matthias, Hollevoet Nadine
Acta Orthop Belg. 2020 Mar;86(1):131-136.
Outcomes of 66 Arpe prostheses in 50 patients treated for osteoarthritis of the trapeziometacarpal joint were investigated with a mean follow-up of ten years. Ten-year survival was 87% when failure was defined as implant removal followed by trapeziectomy and tendon interposition. Ten-year survival was 82% when revision of the cup was also considered as failure and it was 80% when replacement of the neck alone was also chosen as an endpoint. Of the 52 prostheses that were not revised mean DASH score was 11, mean pain score 1.2 and mean score for satisfaction 9.5. It can be concluded that the majority of patients who did not underwent revision surgery were satisfied and had little or no pain. However, long-term survival of the Arpe prosthesis was moderate and patients should be warned that after ten years the risk for reoperation might be up to 20%.
对50例接受大多角骨-第一掌骨关节骨关节炎治疗的患者植入的66个Arpe假体的结果进行了调查,平均随访时间为10年。当将失败定义为取出植入物后进行大多角骨切除术和肌腱间置术时,10年生存率为87%。当杯状假体翻修也被视为失败时,10年生存率为82%;当仅将颈部置换作为终点时,10年生存率为80%。在未进行翻修的52个假体中,平均上肢功能障碍评分(DASH)为11分,平均疼痛评分为1.2分,平均满意度评分为9.5分。可以得出结论,大多数未接受翻修手术的患者感到满意,几乎没有疼痛。然而,Arpe假体的长期生存率中等,应告知患者,10年后再次手术的风险可能高达20%。